Colposcopy Training Masterclass in Riga

Colposcopy Training Masterclass in Riga

Colposcopy Training Masterclass in Riga A Step Towards Unified and High-Quality Cervical Cancer Prevention Across Europe Colposcopy Training Masterclass in Riga At the end of October, the Riga Stradins University (RSU) Institute of Public Health hosted a masterclass for colposcopy training specialists as part of the project Implementation of cancer screening programmes (EUCanScreen). The training […]

Belgium Cervical Cancer Screening Programme

Belgium takes a new step in cervical cancer prevention!

Belgium: Screening Campaign Country Cervical Cancer Screening Programme What is the Cervical Cancer Screening Programme? In Flanders, women aged 25 to 64 are invited to take part in the Cervical Cancer Screening Programme, organised by the Flemish Government.The programme offers a free smear test (Pap test) every three years to detect early cell changes before […]

Towards Smarter, More Precise and More Effective Healthcare – Insights from the Conference on Personalised Cancer Screening in Riga, Latvia

Riga Conference 081025

Latvia, Riga, 08-10-2025 Towards Smarter, More Precise and More Effective Healthcare – Insights from the Conference on Personalised Cancer Screening in Riga, Latvia Insights from the Conference on Personalised Cancer Screening in Riga, Latvia On 8 October, the international conference “Personalised Cancer Screening – Lessons Learned and the Way Forward” took place in Riga, at […]

Belgium Advances Cervical Cancer Prevention with HPV-Based Screening

cervical cancer prevention

Belgium Advances Cervical Cancer Prevention with HPV-Based Screening Transitioning from Pap test screening to primary HPV-based screening Belgium Advances Cervical Cancer Prevention with HPV-Based Screening Brussels, Belgium — Effective 1 January 2025, Belgium has officially transitioned from cytology-based (Pap test) screening to primary HPV-based screening for cervical cancer. This marks a major advancement in evidence-based […]

International Conference in Riga on Personalised Cancer Screening Brings Together Europe’s Leading Experts

International Conference Personalised cancer screening – lessons ch

Latvia, Riga, 08-10-2025 International Conference in Riga on Personalised Cancer Screening Brings Together Europe’s Leading Experts Personalised Cancer Screening Conference On 8 October, the international conference “Personalised Cancer Screening – Lessons Learned and the Way Forward” took place at the University of Latvia in Riga.   Organised as part of the EUCanScreen Joint Action, the […]

IARC launches public consultation on cervical cancer screening approaches

cervical cancer screening

IARC launches public consultation on cervical cancer screening approaches Stakeholder consultation on innovative screening methods for cervical cancer Cervical Cancer Screening On 30 September 2025, IARC opened a global consultation to gather expert and stakeholder input on future cervical cancer screening strategies. Cervical cancer, largely preventable through HPV vaccination and timely testing, still causes significant […]

Evidence-Based Approaches to HPV Screening Implementation

Evidence Based Approaches to HPV Screening Implementation ch

e-oncologia Advancing Cancer Prevention Through Education Evidence-Based Approaches to HPV Screening Implementation Cervical cancer screening is evolving globally due to advances in HPV-based testing, self-sampling, and widespread HPV vaccination. Register Now Course Information This comprehensive online course provides healthcare providers with the latest evidence and practical tools to enhance HPV-based screening, quality assurance, and programme […]

National Cervical Cancer Screening Program in France: Progress and Challenges

National Cervical Cancer Screening Program in France Progress and Challenges

National Cervical Cancer Screening Program in France Progress and Challenges National Cervical Cancer Screening Program in France   Established in 2018, the National Cervical Cancer Screening Program targets all women aged 25 to 65, including pregnant women, postmenopausal women, and women vaccinated against Human Papillomavirus (HPV). Each year, over 10 million women benefit from this […]

HPV vaccination and a future without cervical cancer

HPV vaccination and a future without cervical cancer

HPV vaccination and a future without cervical cancer Awareness-raising event for influencers and bloggers in Tajikistan — WHO Europe event on HPV vaccine introduction HPV vaccination vs cervical cancer WHO/Europe organized an event in Dushanbe (Tajikistan) with influencers and bloggers to support the upcoming introduction of the HPV vaccine in 2025. The goal was to […]

Global burden of cancer attributable to HIV

Cancer attributable to HIV

Global burden of cancer attributable to HIV A worldwide incidence analysis Cancer attributable to HIV Scientists from the International Agency for Research on Cancer (IARC) provide the first global assessment of the burden of cancer attributable to infection with HIV, in a new study published in The Lancet Global Health. The researchers also examined the burden […]